ACE2 and COVID-19: Additionally, the upregulation of ACE2 in lung tissue during acute pneumonia could potentially accelerate viral transmission, suggesting that combination therapies involving antiviral and anti-inflammatory drugs could provide a more comprehensive treatment approach for COVID-19 and related respiratory diseases [13].